These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21917592)

  • 1. Refining the high-dose streptozotocin-induced diabetic non-human primate model: an evaluation of risk factors and outcomes.
    Graham ML; Mutch LA; Rieke EF; Kittredge JA; Faig AW; DuFour TA; Munson JW; Zolondek EK; Hering BJ; Schuurman HJ
    Exp Biol Med (Maywood); 2011 Oct; 236(10):1218-30. PubMed ID: 21917592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of adverse side-effects after chemotherapy in macaques as exemplified by streptozotocin: case studies and recommendations.
    Graham ML; Mutch LA; Kittredge JA; Rieke EF; Robinson NA; Zolondek EK; Faig AW; Dufour TA; Munson JW; Schuurman HJ
    Lab Anim; 2012 Jul; 46(3):178-92. PubMed ID: 22577153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys.
    Jin X; Zeng L; He S; Chen Y; Tian B; Mai G; Yang G; Wei L; Zhang Y; Li H; Wang L; Qiao C; Cheng J; Lu Y
    Exp Biol Med (Maywood); 2010 Jul; 235(7):877-85. PubMed ID: 20558842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses.
    Rood PP; Bottino R; Balamurugan AN; Smetanka C; Ezzelarab M; Busch J; Hara H; Trucco M; Cooper DK
    Pancreas; 2006 Oct; 33(3):287-92. PubMed ID: 17003651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the induction of diabetes in juvenile cynomolgus monkeys with different doses of streptozotocin.
    Zou C; Wang J; Wang S; Huang F; Ren Z; Chen Z; Zhang Y
    Sci China Life Sci; 2012 Mar; 55(3):210-8. PubMed ID: 22527517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe induction of diabetes by high-dose streptozotocin in pigs.
    Hara H; Lin YJ; Zhu X; Tai HC; Ezzelarab M; Balamurugan AN; Bottino R; Houser SL; Cooper DK
    Pancreas; 2008 Jan; 36(1):31-8. PubMed ID: 18192878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
    Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
    Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice.
    Ventura-Sobrevilla J; Boone-Villa VD; Aguilar CN; Román-Ramos R; Vega-Avila E; Campos-Sepúlveda E; Alarcón-Aguilar F
    Proc West Pharmacol Soc; 2011; 54():5-9. PubMed ID: 22423571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction, management, and complications of streptozotocin-induced diabetes mellitus in rhesus monkeys.
    Kim JM; Shin JS; Min BH; Kim HJ; Kim JS; Yoon IH; Jeong WY; Lee GE; Kim MS; Kim JE; Jin SM; Park CG
    Xenotransplantation; 2016 Nov; 23(6):472-478. PubMed ID: 27677911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relations between doses of streptozotocin and pathosis in induced diabetes mellitus].
    Nishigaki A; Noma H; Kakizawa T
    Shikwa Gakuho; 1989 Mar; 89(3):639-62. PubMed ID: 2533996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis).
    Theriault BR; Thistlethwaite JR; Levisetti MG; Wardrip CL; Szot G; Bruce DS; Rilo H; Li X; Gray GS; Bluestone JA; Padrid PA
    Transplantation; 1999 Aug; 68(3):331-7. PubMed ID: 10459535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of diabetes with signs of autoimmunity in primates by the injection of multiple-low-dose streptozotocin.
    Wei L; Lu Y; He S; Jin X; Zeng L; Zhang S; Chen Y; Tian B; Mai G; Yang G; Zhang J; Wang L; Li H; Markmann JF; Cheng J; Deng S
    Biochem Biophys Res Commun; 2011 Aug; 412(2):373-8. PubMed ID: 21821007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates.
    Wijkstrom M; Kirchhof N; Graham M; Ingulli E; Colvin RB; Christians U; Hering BJ; Schuurman HJ
    Toxicology; 2005 Feb; 207(1):117-27. PubMed ID: 15590127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of diabetes in rhesus monkeys and establishment of insulin administration strategy.
    Qiao CF; Tian BL; Mai G; Wei LL; Jin X; Ren Y; Chen YN; Li HX; Li YP; Wang L; Cheng JQ; Lu YR
    Transplant Proc; 2009; 41(1):413-7. PubMed ID: 19249568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment and application of the model of islet impaired by NO free radical released from streptozotocin].
    Qian FY; Ouyang F; Fu DX; Ren TR
    Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):349-52. PubMed ID: 15969020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental model for studies of fetal maldevelopment in the diabetic pregnancy.
    Kemnitz JW; Perelman RH; Engle MJ; Farrell PM
    Pediatr Pulmonol; 1985; 1(3 Suppl):S79-85. PubMed ID: 4069805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different diabetogenic response to moderate doses of streptozotocin in pregnant rats, and its long-term consequences in the offspring.
    López-Soldado I; Herrera E
    Exp Diabesity Res; 2003; 4(2):107-18. PubMed ID: 14630572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.